Commit To Purchase Coherus BioSciences At $2, Earn 42.6% Annualized Using Options
March 19, 2024 at 12:29 PM EDT
Investors eyeing a purchase of Coherus BioSciences Inc (CHRS) shares, but cautious about paying the going market price of $2.37/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $2 strike, which has a bid at the time of this writing of 35 cents..